Table 3.
Allele | Controls (n = 215) | Breast cancer (n = 173) | P value† | |
---|---|---|---|---|
DR1 | *0101 | 11.6% (25) | 13.3% (23) | 0.6442 |
*0102 | 4.2% (9) | 5.8% (10) | 0.4875 | |
*0103 | 2.8% (6) | 5.8% (10) | 0.1984 | |
DR2 | *1501 | 27.9% (60) | 20.2% (35) | 0.0963 |
*1502 | 0.9% (2) | 1.7% (3) | 0.6597 | |
*1503 | 0.9% (2) | 0.6% (1) | 1.0000 | |
*1601 | 2.8% (6) | 2.9% (5) | 1.0000 | |
*1602 | 1.4% (3) | 1.2% (2) | 1.0000 | |
DR3 | *0301–02 | 20.5% (44) | 30.1% (52) | 0.0333 |
DR4 | *0401 | 6.5% (14) | 4.0% (7) | 0.3684 |
*0402 | 5.6% (12) | 4.6% (8) | 0.8183 | |
*0403 | 1.4% (3) | 0.0% (0) | 0.2569 | |
*0404 | 10.7% (23) | 11.6% (20) | 0.8711 | |
*0405 | 1.9% (4) | 0.6% (1) | 0.3865 | |
*0407 | 2.3% (5) | 1.2% (2) | 0.4682 | |
*0408 | 7.4% (16) | 6.4% (11) | 0.8413 | |
*0409 | 0.0% (0) | 0.0% (0) | — | |
*0410 | 0.0% (0) | 0.0% (0) | — | |
*0411 | 0.0% (0) | 0.0% (0) | — | |
DR7 | *0701 | 19.5% (42) | 24.9% (43) | 0.2189 |
DR8 | *0801–04 | 4.2% (9) | 6.4% (11) | 0.3632 |
DR9 | *0901A/B | 2.8% (6) | 0.6% (1) | 0.1370 |
DR10 | *1001 | 0.9% (2) | 1.2% (2) | 1.0000 |
DR11 | *1101–04 | 16.3% (35) | 3.5% (6) | <0.0001‡ |
DR12 | *1201–02 | 3.2% (7) | 5.2% (9) | 0.4425 |
DR13 | *1301 | 5.1% (11) | 0.6% (1) | 0.0147 |
*1302 | 10.2% (22) | 12.1% (21) | 0.6263 | |
*1303 | 0.9% (2) | 4.6% (8) | 0.0268 | |
*1304 | 0.0% (0) | 0.0% (0) | — | |
*1305 | 0.0% (0) | 0.6% (1) | 0.4459 | |
DR14 | *1401 | 5.1% (11) | 1.2% (2) | 0.0441 |
*1402 | 0.0% (0) | 0.6% (1) | 0.4459 | |
*1403 | 6.5% (14) | 7.5% (13) | 0.6944 | |
*1404 | 1.9% (4) | 1.2% (2) | 0.6961 | |
*1405 | 2.8% (6) | 5.8% (10) | 0.1984 | |
*1406 | 0.0% (0) | 0.0% (0) | — | |
*1407 | 0.0% (0) | 0.0% (0) | — | |
*1408 | 0.0% (0) | 0.0% (0) | — |
Uncorrected two-tailed P value (Fisher's Exact Test).
Significant after correction; nominal value for comparison, P ≤ 0.0016.